Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Sep;5(5):597-603.
doi: 10.1128/CDLI.5.5.597-603.1998.

Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection

J L Fahey  1
Affiliations
Review

Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection

J L Fahey. Clin Diagn Lab Immunol. 1998 Sep.
No abstract available

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Schematic representation of some of the significant cytokine-mediated interactions between T cells and macrophages (Mφ) during HIV infection.
FIG. 2
FIG. 2
POP for occurrence of AIDS. This graphic method allows ready comprehension and comparison of several surrogate markers. Calculations are based on survival analysis regression methods with Gaussian error distribution, as described in detail in reference . Lower values are better; a perfect predictor would be one that had zero deviation and could predict future occurrence of AIDS to a precise day. This would have a scale value of zero. (A) Illustrative diagram of three hypothetical surrogate markers, X, Y, and Z. In this example, assay Y is not as good as X but is better than Z. (B) Graphic presentation of several surrogate markers. A group of 659 seropositive men with mean CD4 T-cell levels of 514/mm3 were evaluated for prediction of AIDS occurrence within 3 years (25). SP, prognostic precision for the study population as a whole without surrogate markers; T, plasma sTNF-α–RII levels; 4, CD4 T-cell levels; H, plasma HIV concentration; C1, combined value for CD4 T cells plus HIV load; C2, combined value for CD4 T cells plus sTNF-α–RII.
See this image and copyright information in PMC

References

    1. Ascher M S, Sheppard H W. AIDS as immune system activation. II. The panergic imnesia hypothesis. J Acquired Immune Defic Syndr. 1990;3:177–191. - PubMed
    1. Aukrust P, Liabakk N B, Müller F, Lien E, Espevik T, Froland S S. Serum levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection. Correlations to clinical immunologic and virologic parameters. J Infect Dis. 1994;169:420–424. - PubMed
    1. Bass H Z, Hardy D W, Mitsuyasu R T, Taylor J M, Wang Y X, Fischl M A, Spector S A, Richman D D, Fahey J L. The effect of zidovudine treatment on serum neopterin and β2-microglobulin levels in mildly symptomatic human immunodeficiency virus type-1 (HIV-1) seropositive individuals. J Acquired Immune Defic Syndr. 1992;5:215–221. - PubMed
    1. Bass H Z, Fahey J L, Nishanian P, Detels R, Cumberland W, Kemeny M, Plaeger S. Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes. Clin Diagn Lab Immunol. 1997;4:64–69. - PMC - PubMed
    1. Bass H Z, Nishanian P, Hardy W D, Mitsuyasu R T, Esmail E, Cumberland W, Fahey J L. Immune changes in HIV infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin Immunol Immunopathol. 1992;64:63–70. - PubMed

Publication types